IL17A and diffuse large B-cell lymphoma: Among these pathways, hsa04650 (natural killer cell-mediated cytotoxicity), hsa04657 (IL-17 signaling pathway) and hsa04060 (cytokine-cytokine receptor interaction) were involved in the tumorigenesis and pathogenesis of DLBCL (Fig. 6A–D).